752 related articles for article (PubMed ID: 10401706)
1. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
2. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-blind placebo-controlled study with open follow-up.
Finkenstedt G; Gasser RW; Höfle G; Watfah C; Fridrich L
Eur J Endocrinol; 1997 Mar; 136(3):282-9. PubMed ID: 9100553
[TBL] [Abstract][Full Text] [Related]
3. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
Janssen YJ; Hamdy NA; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
[TBL] [Abstract][Full Text] [Related]
4. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
Sneppen SB; Hoeck HC; Kollerup G; Sørensen OH; Laurberg P; Feldt-Rasmussen U
Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
[TBL] [Abstract][Full Text] [Related]
7. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
Sartorio A; Conte G; Conti A; Masala A; Alagna S; Rovasio P; Faglia G
J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
[TBL] [Abstract][Full Text] [Related]
8. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.
Kotzmann H; Riedl M; Bernecker P; Clodi M; Kainberger F; Kaider A; Woloszczuk W; Luger A
Calcif Tissue Int; 1998 Jan; 62(1):40-6. PubMed ID: 9405732
[TBL] [Abstract][Full Text] [Related]
10. Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.
Sartorio A; Ortolani S; Galbiati E; Conte G; Vangeli V; Arosio M; Porretti S; Faglia G
J Endocrinol Invest; 2001 Apr; 24(4):224-30. PubMed ID: 11383908
[TBL] [Abstract][Full Text] [Related]
11. Elderly patients with adult-onset growth hormone deficiency are not osteopenic.
Toogood AA; Adams JE; O'Neill PA; Shalet SM
J Clin Endocrinol Metab; 1997 May; 82(5):1462-6. PubMed ID: 9141534
[TBL] [Abstract][Full Text] [Related]
12. Bone marker alterations in patients with type 1 Gaucher disease.
Ciana G; Martini C; Leopaldi A; Tamaro G; Katouzian F; Ronfani L; Bembi B
Calcif Tissue Int; 2003 Mar; 72(3):185-9. PubMed ID: 12522660
[TBL] [Abstract][Full Text] [Related]
13. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults.
Välimäki MJ; Salmela PI; Salmi J; Viikari J; Kataja M; Turunen H; Soppi E
Eur J Endocrinol; 1999 Jun; 140(6):545-54. PubMed ID: 10377504
[TBL] [Abstract][Full Text] [Related]
14. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
16. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males.
Vandeweghe M; Taelman P; Kaufman JM
Clin Endocrinol (Oxf); 1993 Oct; 39(4):409-15. PubMed ID: 8287567
[TBL] [Abstract][Full Text] [Related]
17. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults.
Beshyah SA; Kyd P; Thomas E; Fairney A; Johnston DG
Clin Endocrinol (Oxf); 1995 Mar; 42(3):249-54. PubMed ID: 7758229
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
[TBL] [Abstract][Full Text] [Related]
19. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study.
Hansen TB; Brixen K; Vahl N; Jørgensen JO; Christiansen JS; Mosekilde L; Hagen C
J Clin Endocrinol Metab; 1996 Sep; 81(9):3352-9. PubMed ID: 8784096
[TBL] [Abstract][Full Text] [Related]
20. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
Beshyah SA; Thomas E; Kyd P; Sharp P; Fairney A; Johnston DG
Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
